Literature DB >> 7039329

Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.

R H Rengstorff, C B Doughty.   

Abstract

Complications from mydriatic and cycloplegic drugs are rare compared with their extensive use. Adverse effects are often related to dosage or other factors. The ocular complications include increased intraocular pressure, pigmentation of the conjunctiva and cornea, pigment in the anterior chamber, lacrimal duct blockage, macular edema, corneal endothelium damage, hyperemia, allergy, discomfort, and blurred vision. The systemic complications are those common to sympathomimetic and parasympatholytic drugs and include tachycardia, hypertension, headache, faintness. pallor, trembling, excessive sweating, palpitations, arrhythmias, confusion, hallucinations, drowsiness, ataxia, flushed skin, high fever, dysarthria, thirst, dry mouth, convulsions, disorientation, nervousness, coma, and death. An understanding of all possible side effects is of paramount importance to those using these drugs in the treatment of anticholinesterase poisoning. This review is intended as a ready reference to the adverse effects of mydriatic and cycloplegic drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039329

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  9 in total

1.  Reduction in mydriatic drop size in premature infants.

Authors:  S Wheatcroft; A Sharma; J McAllister
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

2.  Comparative Study of the Effects of 1% Atropine on the Anterior Segment.

Authors:  Yue Zhou; Xiao Bo Huang; Qi Cai; Jun Jie Li; Yao Jia Xiong; Ye Xun Gong; Li Wei Lin; Yan Zhu; Zhi Min Sun
Journal:  J Ophthalmol       Date:  2020-09-28       Impact factor: 1.909

Review 3.  Cycloplegia in Children: An Optometrist's Perspective.

Authors:  Erin Major; Thomas Dutson; Majid Moshirfar
Journal:  Clin Optom (Auckl)       Date:  2020-08-25

Review 4.  Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.

Authors:  Tatiana V Tkatchenko; Andrei V Tkatchenko
Journal:  Trends Pharmacol Sci       Date:  2019-10-30       Impact factor: 14.819

5.  Changes in intraocular pressure after pharmacologic pupil dilation.

Authors:  Joon Mo Kim; Ki Ho Park; So Young Han; Kwan Soo Kim; Dong Myung Kim; Tae Woo Kim; Joseph Caprioli
Journal:  BMC Ophthalmol       Date:  2012-09-27       Impact factor: 2.209

6.  Self correction of refractive error among young people in rural China: results of cross sectional investigation.

Authors:  Mingzhi Zhang; Riping Zhang; Mingguang He; Wanling Liang; Xiaofeng Li; Lingbing She; Yunli Yang; Graeme Mackenzie; Joshua D Silver; Leon Ellwein; Bruce Moore; Nathan Congdon
Journal:  BMJ       Date:  2011-08-09

7.  Pupil Dilation with Intracameral Epinephrine Hydrochloride during Phacoemulsification and Intraocular Lens Implantation.

Authors:  A-Yong Yu; Hua Guo; Qin-Mei Wang; Fang-Jun Bao; Jing-Hai Huang
Journal:  J Ophthalmol       Date:  2016-01-20       Impact factor: 1.909

8.  Changes in intraocular pressure and horizontal pupil diameter during use of topical mydriatics in the canine eye.

Authors:  Liga Kovalcuka; Agris Ilgazs; Dace Bandere; David L Williams
Journal:  Open Vet J       Date:  2017-01-27

9.  Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery.

Authors:  Marc Labetoulle; Oliver Findl; François Malecaze; Jorge Alió; Béatrice Cochener; Conceição Lobo; Sihem Lazreg; Dahbia Hartani; Joseph Colin; Marie-José Tassignon; Anders Behndig
Journal:  Br J Ophthalmol       Date:  2015-11-03       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.